Cargando…

Adverse Effects Associated with Proton Pump Inhibitor Use

Proton pump inhibitors (PPIs) marked a before and after in the management of gastric acid‐related disorders since their introduction to the market in 1989. Due to a novel, highly effective mechanism of action blocking the last converging step of gastric acid secretion by parietal cells and very few...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yibirin, Marcel, De Oliveira, Diana, Valera, Roberto, Plitt, Andrea E, Lutgen, Sophia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887997/ https://www.ncbi.nlm.nih.gov/pubmed/33614352 http://dx.doi.org/10.7759/cureus.12759

Ejemplares similares

A Case of Dysembryoplastic Neuroepithelial Tumor in an Adolescent Male
por: Yibirin, Marcel, et al.
Publicado: (2021)

Unusual Neurological Manifestation of Proton Pump Inhibitor: A Case Report of Acute Disseminated Encephalomyelitis and Severe Hyponatremia After Brief Use of Proton Pump Inhibitor
por: Qureshi, Ahmad S, et al.
Publicado: (2021)

Reducing the Inappropriate Use of Proton Pump Inhibitors in an Internal Medicine Residency Clinic
por: Boster, Joshua, et al.
Publicado: (2020)

A Study of Proton Pump Inhibitors and Other Risk Factors in Warfarin-Associated Gastrointestinal Bleeding
por: Tang, Jevon, et al.
Publicado: (2021)

Primary Sclerosing Cholangitis-Autoimmune Hepatitis Overlap Syndrome: Significant Barriers in Liver Disease Diagnosis and Treatment Experienced by the Latino Community
por: Guifarro, Daniel A, et al.
Publicado: (2023)

Use of Proton Pump Inhibitors With Dexamethasone in Patients With COVID-19 Pneumonia: Contributions to Long-Term Polypharmacy
por: Singh, Ranbir, et al.
Publicado: (2022)

Prevalence and Risk Factors Associated With Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study
por: Onwuzo, Somtochukwu, et al.
Publicado: (2023)

A Randomized Open-Label Study of Two Methods of Proton Pump Inhibitors Discontinuation
por: Hendricks, Emily, et al.
Publicado: (2021)

Assessment of Awareness and Knowledge of Proton Pump Inhibitors Among the General Population in Saudi Arabia
por: Aljahdli, Emad S, et al.
Publicado: (2022)

Osmotic Demyelination Syndrome in a Normonatremic Patient Under Treatment With Proton Pump Inhibitors
por: Romero Calvo, Lidia, et al.
Publicado: (2023)

Skipping the Drip: Intravenous Proton Pump Inhibitor Bolus Therapy Leads to Poor Outcomes in High-Risk Bleeding
por: Khan, Raja Samir, et al.
Publicado: (2020)

The Effects of Proton Pump Inhibitors in Acid Hypersecretion-Induced Vitamin B12 Deficiency: A Systematic Review (2022)
por: Swarnakari, Kiran Maee, et al.
Publicado: (2022)

Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy
por: Karim, Rashid, et al.
Publicado: (2020)

Comparing the Safety and Efficacy of Proton Pump Inhibitors and Histamine-2 Receptor Antagonists in the Management of Patients With Peptic Ulcer Disease: A Systematic Review
por: Begg, Maha, et al.
Publicado: (2023)

Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors
por: Maideen, Naina Mohamed Pakkir
Publicado: (2023)

Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database
por: Zeng, Yifan, et al.
Publicado: (2021)

Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study
por: Wang, Mei, et al.
Publicado: (2022)

Association of Proton Pump Inhibitor and Infection and Major Adverse Clinical Events in Patients With ST-Elevation Myocardial Infarction: A Propensity Score Matching Analysis
por: Liu, Yuan-Hui, et al.
Publicado: (2022)

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events
por: Juurlink, David N., et al.
Publicado: (2013)

Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility
por: Fossmark, Reidar, et al.
Publicado: (2019)

Proton Pump Inhibitor Use before Percutaneous Endoscopic Gastrostomy Is Associated with Adverse Outcomes
por: Im, Jong Pil, et al.
Publicado: (2014)

Multiple White Plaques in the Esophagus: A Possible Case of Esophageal Mucosal Alteration Associated With Immune-Related Adverse Events of Immune Checkpoint Inhibitors
por: Iwamuro, Masaya, et al.
Publicado: (2022)

Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect
por: Srinivasan, Aswin, et al.
Publicado: (2021)

A Case of Proton Pump Inhibitor-induced Fasciitis
por: Nakanishi, Yuki, et al.
Publicado: (2019)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Prolonged Use of Proton Pump Inhibitors, but Not Histamine-2 Receptor Antagonists, Is Associated With Lower Bone Mineral Density in Males Aged Over 70
por: Gao, Shihua, et al.
Publicado: (2021)

ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma
por: SAKAI, Kosei, et al.
Publicado: (2021)

Proton Pump Inhibitor-Induced Hypomagnesemia: A Rare, Potentially Fatal Complication
por: Pawlukiewicz, Alec J, et al.
Publicado: (2020)

Pharmacoeconomic Analysis of Fixed-Dose Combinations of Proton Pump Inhibitors Available in India
por: Deolekar, Pradnya, et al.
Publicado: (2023)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Atezolizumab, a PD-L1 Inhibitor: An Association of Bleeding Gastric Ulcer With Its Use
por: Bapatla, Anusha, et al.
Publicado: (2021)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Rhabdomyolysis: A Rare Adverse Effect of Levetiracetam
por: Rastogi, Vaibhav, et al.
Publicado: (2018)

The Rare Adverse Effect of Cefepime-Induced Neutropenia
por: Jumaah, Omar, et al.
Publicado: (2023)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Adverse Obstetric Outcomes in Pregnant Women Using Natalizumab for the Treatment of Multiple Sclerosis: A Systematic Review
por: Ramesh, Vaiishnavi, et al.
Publicado: (2022)

Association Between Pfizer COVID-19 Vaccine Adverse Effects and Diabetes Mellitus: A Prospective Multicenter Study
por: Akhtar, Syed Mamoon, et al.
Publicado: (2023)

Parkinsonism: A Rare Adverse Effect of Valproic Acid
por: Muralidharan, Abilash, et al.
Publicado: (2020)

Drug-Induced Eosinophilic Pneumonia as an Adverse Event of Abemaciclib
por: Mitarai, Yuki, et al.
Publicado: (2022)

Acid Reflux: A Rare Adverse Effect of Duloxetine
por: Vaghela, Nital, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k2r35pdqrkj7joo7ru96hjomfl